EU says AstraZeneca vaccine supply is global problem, not EU-Australia issue

Coronavirus chronicle

Reuters
07 April, 2021, 05:25 pm
Last modified: 07 April, 2021, 05:25 pm
Canberra has said the EU has blocked shipments, whereas the EU says AstraZeneca had not requested new authorisations for exports to Australia
A vail of the Oxford-AstraZeneca Covid-19 vaccine is seen at Basingstoke Fire Station, in Basingstoke, Britain February 4, 2021. REUTERS/Peter Cziborra/File Photo

The European Commission said on Wednesday that delivery shortfalls of AstraZeneca's Covid-19 vaccine were a global issue, not something to be addressed only in talks between the EU and Australia.

The comment followed Australia's request to the EU to send AstraZeneca doses. Canberra has said the EU has blocked shipments, whereas the EU says AstraZeneca had not requested new authorisations for exports to Australia.

"We're not the only region in the world producing AstraZeneca vaccines, and therefore this is a global issue. It is definitely not simply a bilateral issue between one country and the European Union," a spokesman for the EU Commission told a news conference when asked about Australia's request.

The spokesman said the EU was also facing huge shortfalls of AstraZeneca vaccine deliveries.

Related Topics

World+Biz

EU / AstraZeneca Covid-19 Vaccine / australia

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.